Marshall Financial Group (Maryland)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
1,309
-4,568
| -78% | -$857K | 0.05% | 229 |
|
|
2025
Q1 | $1.23M | Sell |
5,877
-135
| -2% | -$28.3K | 0.27% | 83 |
|
|
2024
Q4 | $1.07M | Buy |
6,012
+435
| +8% | +$77.3K | 0.26% | 97 |
|
|
2024
Q3 | $1.1M | Buy |
5,577
+194
| +4% | +$38.3K | 0.26% | 102 |
|
|
2024
Q2 | $923K | Sell |
5,383
-5,082
| -49% | -$872K | 0.26% | 104 |
|
|
2024
Q1 | $1.91M | Buy |
10,465
+558
| +6% | +$102K | 0.55% | 49 |
|
|
2023
Q4 | $1.54M | Buy |
+9,907
| New | +$1.54M | 0.5% | 55 |
|
|
2023
Q2 | – | Sell |
-1,456
| Closed | -$232K | – | 175 |
|
|
2023
Q1 | $232K | Sell |
1,456
-5,518
| -79% | -$879K | 0.08% | 158 |
|
|
2022
Q4 | $1.13M | Buy |
6,974
+744
| +12% | +$120K | 0.44% | 71 |
|
|
2022
Q3 | $836K | Buy |
6,230
+126
| +2% | +$16.9K | 0.35% | 89 |
|
|
2022
Q2 | $935K | Buy |
+6,104
| New | +$935K | 0.37% | 74 |
|